Jason Sands

47%
Flag icon
Alpha-glucosidase inhibitors DESPITE THE HOOPLA, the SGLT2 was not actually the first oral hypoglycemic agent to show proven cardiovascular benefits. Another now largely forgotten drug was previously shown to have similar benefits.
The Diabetes Code: Prevent and Reverse Type 2 Diabetes Naturally
Rate this book
Clear rating
Open Preview